Efficacy and safety of bevacizumab-based combination therapy for treatment of patients with metastatic colorectal cancer

AIM: The use of bevacizumab in combination therapy is an emerging trend in metastatic colorectal cancer treatment. However, the clinical value of different combination types remains under debate. Thus, a meta-analysis of randomized controlled trials (RCTs) comparing bevacizumab-based combination the...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ran, Xu, Chen, Liu, Chuntong, Cui, Can, Zhu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287670/
https://www.ncbi.nlm.nih.gov/pubmed/30584320
http://dx.doi.org/10.2147/OTT.S171724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287670/
https://www.ncbi.nlm.nih.gov/pubmed/30584320
http://dx.doi.org/10.2147/OTT.S171724

Ejemplares similares